Scholarlink

<p>Colorectal cancer (CRC) chemotherapy remains clinically challenging due to the emergence of drug resistance, off-target toxicity, and suboptimal patient compliance, underscoring the need for innovative, patient-centric delivery systems specially designed for targeted CRC therapy. Oral delivery of chemotherapeutic drugs offers a potential solution, with the benefits of enhanced treatment adherence and patient compliance. However, conventional oral chemotherapy is significantly hindered by multiple physiological, chemical, microbial, and tumor microenvironment-associated barriers within the GIT of CRC patients. In this regard, nanoparticle-based drug delivery systems have emerged as a promising tool to overcome the challenges associated with the distal colon’s anatomical position when delivering chemotherapeutic drugs via the oral route, while simultaneously reducing the risk of non-specific gastrointestinal toxicity. This review uniquely integrates the gastrointestinal and tumor microenvironment barriers encountered in oral chemotherapy for CRC and establishes the rationale for using nanoparticle-based drug delivery and for developing suitable nanoformulations to overcome these barriers and impart therapeutic effects. Moreover, it provides a comprehensive overview of recent advancements in this domain, with particular emphasis on current translational constraints and prospective strategies towards further clinical translation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Nanoparticle-based strategies as emerging tools for oral chemotherapy of colorectal cancer

  • 期刊论文

  • 发表日期：

    2026年5月20日

查看全文
  • Hiranmoy Bhattacharya,
  • Pratik Chakraborty,
  • Subhajit Kandar,
  • Asis Bala,
  • Saikat Dewanjee

摘要

Colorectal cancer (CRC) chemotherapy remains clinically challenging due to the emergence of drug resistance, off-target toxicity, and suboptimal patient compliance, underscoring the need for innovative, patient-centric delivery systems specially designed for targeted CRC therapy. Oral delivery of chemotherapeutic drugs offers a potential solution, with the benefits of enhanced treatment adherence and patient compliance. However, conventional oral chemotherapy is significantly hindered by multiple physiological, chemical, microbial, and tumor microenvironment-associated barriers within the GIT of CRC patients. In this regard, nanoparticle-based drug delivery systems have emerged as a promising tool to overcome the challenges associated with the distal colon’s anatomical position when delivering chemotherapeutic drugs via the oral route, while simultaneously reducing the risk of non-specific gastrointestinal toxicity. This review uniquely integrates the gastrointestinal and tumor microenvironment barriers encountered in oral chemotherapy for CRC and establishes the rationale for using nanoparticle-based drug delivery and for developing suitable nanoformulations to overcome these barriers and impart therapeutic effects. Moreover, it provides a comprehensive overview of recent advancements in this domain, with particular emphasis on current translational constraints and prospective strategies towards further clinical translation.